Iambic Therapeutics, Inc. IAM
13.11 USD -1.15 (-8.06%)
Regular-session close
13.62 +0.51 +3.89%
After hours · Nov 20, 4:00 PM ET
12.77 Day range 14.00
9.60 52-week range 25.00
- YTD
- -30.67%
- 1 year
- -30.67%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 |
|---|---|---|
| 9.43M | 1.19M | |
| 9.43M | 1.19M | |
| -82.35M | -53.88M | |
| -77.30M | -47.88M | |
| -3.57 | -2.23 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 |
|---|---|---|
| 180.54M | 141.58M | |
| 195.02M | 155.75M | |
| 40.25M | 25.34M | |
| 5.46M | 6.21M | |
| -186.56M | -112.25M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 |
|---|---|---|
| -58.82M | -33.56M | |
| -1.28M | -707.00K | |
| 99.06M | 64.99M | |
| -1.28M | -707.00K | |
| 38.96M | 30.73M |
